Related Experiment Videos
Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology
American Journal of Human Genetics
|May 1, 1979
Summary
Familial hyperlysinemia involves deficiencies in key enzymes for lysine metabolism. A new screening test using skin fibroblasts accurately identifies patients with this rare genetic disorder.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Familial hyperlysinemia is a rare genetic disorder affecting lysine metabolism.
- Previous studies reported deficiencies in specific enzymes in affected individuals.
Purpose of the Study:
- To further characterize enzyme deficiencies in familial hyperlysinemia.
- To develop and validate a screening test for the disorder.
- To propose a refined classification for familial hyperlysinemia.
Main Methods:
- Enzyme assays on skin fibroblasts from affected children.
- Partial purification and characterization of saccharopine oxidoreductase from human liver.
- Development of a screening test using 14C-labeled lysine and skin fibroblasts.
Main Results:
- Deficiencies in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase were consistently observed.
- Saccharopine oxidoreductase activity was found to be associated with lysine-ketoglutarate reductase and saccharopine dehydrogenase.
- The developed screening test effectively differentiated familial hyperlysinemia patients from controls.
Conclusions:
- The study confirms enzyme deficiencies in familial hyperlysinemia and provides a reliable screening method.
- A proposed classification (Type I and Type II) based on enzyme defect severity is suggested.
- Understanding these enzyme defects aids in diagnosing and managing familial hyperlysinemia.